August 29, 2016
From Our 2011 Archives
font size

Experts Propose Age-Based Hepatitis C Testing

Screening People Born From 1946 to 1970 Would Prevent Advanced Disease, Model Shows; Other Experts Want More Evidence

By Kathleen Doheny
WebMD Health News

Reviewed By Louise Chang, MD

May 9, 2011 -- Screening all people born between 1946 and 1970 for the hepatitis C virus would greatly reduce the number of people with advanced liver disease linked with the virus, according to new research.

''Current recommendations are to screen high-risk people," says researcher Lisa McGarry, MPH, director of health economics and outcomes research at Ingenix Life Sciences, a health information, technology, and consulting service.

Intravenous drug users are considered at high risk.

McGarry and her colleagues suggest that all people in the age group known as baby boomers, along with those born a few years after, be screened.

Hepatitis C is a contagious liver disease. It ranges in severity. It can be a mild illness that lasts just a few weeks to a more serious, chronic disease that attacks the liver.

McGarry presented her research yesterday at Digestive Disease Week in Chicago.

The study was funded by Vertex Pharmaceuticals. The company is developing a hepatitis C drug, telaprevir.

Otther experts who reviewed the research say the model is not enough information to suggest a change in the recommendation for hepatitis C testing.

Hepatitis C Testing: The Disease Model

Using a computerized model of disease progression, the researchers projected the outcomes for the age-based screening they propose.

They chose the baby boomer population as well as those born a few years after because the hepatitis C infection rate is particularly high among them. According to the researchers, about 1.6 million people in the U.S. aged 40 to 64 are infected but do not know it.

The virus is spread primarily through contact with the blood of an infected person, according to the CDC. Most people become infected by sharing needles or other equipment used to inject IV drugs.

People who got a blood transfusion before 1992, when screening of the blood supply became available, are also at risk. Less often, people become infected when sharing personal care items such as toothbrushes or razors that have been in contact with an infected person's blood. Infection can occur after having sex with an infected person, but that risk is considered low. The risk becomes greater if a person has multiple sex partners, rough sex, an STD, or HIV.

Health care workers who have needlestick injuries when caring for an infected person can also become infected.

Using the model, the researchers determined how many people would be infected and undiagnosed without age-based screening. They computed how far the disease would have progressed.

Next, they looked at the effect of screening the entire population in that age range. They looked at how screening and detection would affect progression to advanced liver disease, if infected, and to death.

Age-based screening is worth it, they conclude.

''The age-based screening program could prevent more than 100,000 cases of advanced liver disease and save almost 60,000 lives over the course of the lifetime of this group born from 1946 to 1970," McGarry tells WebMD.

It would prevent more than 7,000 liver transplants, McGarry tells WebMD.

The eligible population, she estimates, would be about 101 million.

The test is a blood test and costs about $30, she says. It detects antibodies to the virus. If that test is positive, a second test is done to confirm.

Earlier treatment due to earlier detection would result in a net cost saving to the health care system, the researchers say.


Lisa McGarry, MPH, director of health economics and outcomes research, Ingenix Life Sciences.

Digestive Disease Week, Chicago, May 7-10, 2011.

Aaron E. Glatt, MD, president and chief executive officer, St. Joseph Hospital, Bethpage, NY; spokesman, Infectious Diseases Society of America; clinical professor of medicine, New York Medical College.

Virginia Moyer, MD, chair, U.S. Preventive Services Task Force; professor of pediatrics, Baylor College of Medicine, chief quality officer for medicine, Texas Children's Hospital, Houston.

© 2011 WebMD, LLC. All rights reserved.

Women's Health

Find out what women really need.

Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations